Ciprofibrate For Hyperlipidemia: What You Need To Know
Ciprofibrate tablets treat high blood lipid levels, reducing heart disease risk when statins are unsuitable.
Ciprofibrate is a fibrate medication prescribed to treat hyperlipidaemia, a condition characterized by elevated levels of lipids such as triglycerides and cholesterol in the blood. It primarily targets severe hypertriglyceridaemia, often with low HDL cholesterol, and mixed hyperlipidaemia when statins are contraindicated or not tolerated. By activating PPAR-alpha receptors, ciprofibrate reduces triglyceride production and increases their breakdown, while modestly raising HDL cholesterol. Clinical evidence shows it lowers triglycerides by up to 44%, boosts HDL by 10%, and improves endothelial function, reducing cardiovascular risks.
About ciprofibrate
Hyperlipidaemia involves high blood fats that do not cause immediate symptoms but increase risks of atherosclerosis, heart attacks, strokes, and vascular diseases over time. Ciprofibrate, a peroxisome proliferator-activated receptor alpha (PPARα) agonist, effectively manages this by altering lipid metabolism. It is indicated for Fredrickson types IIa, IIb, III, and IV hyperlipidaemias, complementing dietary therapy.
In clinical trials, patients with hypertriglyceridaemia experienced significant improvements: triglycerides dropped 44% (p<0.001), HDL rose 10.1% (p<0.001), and non-HDL cholesterol fell 19% after 4 months of ciprofibrate plus diet. Lean patients (BMI <25 kg/m²) saw greater HDL increases (19.7% vs 8.2%), while overweight individuals had more non-HDL reduction. In type 2 diabetes, it attenuated postprandial lipemia, improved flow-mediated dilatation (endothelial function), and reduced oxidative stress.
Unlike statins, which primarily lower LDL cholesterol, ciprofibrate excels at triglyceride reduction and HDL elevation, making it suitable for statin-intolerant patients or mixed dyslipidaemias. Regular lipid monitoring ensures efficacy, with lifestyle changes enhancing outcomes.
Before taking ciprofibrate
Consult your doctor before starting ciprofibrate, especially if you have liver or kidney issues, gallbladder disease, or a history of muscle disorders like myopathy. It is contraindicated in severe hepatic/renal impairment, pregnancy, breastfeeding, or photosensitivity history.
Inform your doctor of all medications, as ciprofibrate interacts with statins (rhabdomyolysis risk), anticoagulants (enhanced bleeding), and oral contraceptives. Baseline blood tests for liver enzymes, kidney function, and lipids are essential. Avoid if you have peptic ulcers or are allergic to fibrates.
- Pregnancy and breastfeeding: Not recommended; potential fetal harm reported in animal studies.
- Driving/operating machinery: May cause dizziness; avoid if affected.
- Alcohol: Limit intake, as it raises triglycerides.
- Diabetes: Monitor blood sugar closely, as fibrates may alter glycemic control.
How to take ciprofibrate
The standard dose is one 100 mg tablet daily, swallowed whole with water, preferably at the same time each day. It can be taken with or without food, but consistency aids adherence. Do not exceed the prescribed dose or stop abruptly without medical advice.
For renal impairment, dose adjustment may be needed; avoid in severe cases. Treatment is long-term, with lipid checks every 3-6 months to assess response. If levels do not improve after 3-4 months, your doctor may adjust therapy.
| Patient Group | Dosage | Notes |
|---|---|---|
| Adults | 100 mg once daily | With dietary measures |
| Elderly | 100 mg once daily | Monitor renal function |
| Renal impairment (mild) | 100 mg every other day | Adjust based on creatinine clearance |
| Children | Not recommended | Safety not established |
Getting the most from your treatment
Combine ciprofibrate with lifestyle modifications for optimal results. A heart-healthy diet low in saturated fats, sugars, and alcohol, rich in fruits, vegetables, and omega-3s, enhances lipid reduction.
- Diet: Reduce total fat to <30% of calories; prioritize unsaturated fats. Limit refined carbs and alcohol.
- Exercise: Aim for 150 minutes weekly of moderate activity like walking or swimming to boost HDL and lower triglycerides.
- Weight management: Losing 5-10% body weight if overweight improves response, especially non-HDL reduction.
- Smoking cessation: Quitting improves HDL and vascular health.
- Salt reduction: Lowers blood pressure, aiding overall cardiovascular protection.
Track progress with regular check-ups. Studies confirm diet plus ciprofibrate yields superior lipid profiles vs diet alone.
Can ciprofibrate cause problems?
Most people tolerate ciprofibrate well, but side effects occur in some. Common ones are mild and transient; report persistent or severe issues promptly.
| Side Effect | Common (>1/100) | Rare/Serious | What to Do |
|---|---|---|---|
| Gastrointestinal | Indigestion, nausea, stomach pain, diarrhoea | Pancreatitis | Simple foods; hydrate; see doctor if severe |
| Nervous system | Headache, dizziness | – | Painkillers, fluids; avoid driving |
| Musculoskeletal | Muscle aches | Rhabdomyolysis (with statins) | Contact doctor immediately |
| Skin/Hair | Rash, hair loss, itching | Photosensitivity | Sun protection; consult doctor |
| Other | Fatigue, vertigo | Liver enzyme elevation, gallstones | Monitor blood tests |
Serious risks include myopathy (muscle pain/weakness), hepatotoxicity, or renal issues—seek urgent care for dark urine, jaundice, or severe pain. Incidence of rhabdomyolysis rises with statins; avoid combination unless monitored.
How to store ciprofibrate
Store below 25°C in original packaging, away from moisture, heat, and children. Do not use after expiry date. Return unused tablets to pharmacy for disposal.
Important information about all medicines
- Never share prescription medicines.
- Take exactly as directed; inform doctor of changes.
- Mention ciprofibrate when seeking other treatments.
- Check expiry dates.
- Forgetting a dose: Take soon as remembered unless near next; do not double.
Frequently Asked Questions (FAQs)
Q: Who should take ciprofibrate?
A: Those with severe hypertriglyceridaemia or mixed hyperlipidaemia unresponsive to diet/statins.
Q: How quickly does it work?
A: Lipid improvements seen within weeks; full effects in 3-4 months with monitoring.
Q: Can I drink alcohol on ciprofibrate?
A: Limit or avoid; alcohol elevates triglycerides.
Q: Does it interact with statins?
A: Yes, increased myopathy risk; use only under close supervision.
Q: Is ciprofibrate safe long-term?
A: Yes, with regular monitoring of liver/kidney function and lipids.
Q: What if I miss a dose?
A: Take as soon as possible; skip if near next dose. Do not double up.
References
- Ciprofibrate 100mg Tablets – Summary of Product Characteristics — electronic Medicines Compendium (emc). 2023. https://www.medicines.org.uk/emc/product/6650/smpc
- Ciprofibrate therapy in patients with hypertriglyceridemia and low HDL cholesterol — PMC (PubMed Central). 2006-09-14. https://pmc.ncbi.nlm.nih.gov/articles/PMC503398/
- Ciprofibrate Therapy Improves Endothelial Function and Reduces Oxidative Stress in Type 2 Diabetes — American Heart Association Journals. 2000-04-10. https://www.ahajournals.org/doi/10.1161/01.cir.101.15.1773
- Ciprofibrate for hyperlipidaemia — Patient.info. Accessed 2026. https://patient.info/medicine/ciprofibrate-for-hyperlipidaemia
- Assessment report: Fenofibrate, bezafibrate, ciprofibrate and gemfibrozil — European Medicines Agency (EMA). 2017. https://www.ema.europa.eu/en/documents/referral/assessment-report-fenofibrate-bezafibrate-ciprofibrate-and-gemfibrozil-containing-medicinal-products_en.pdf
Similar Articles
Read full bio of Sneha Tete
